Form D · Other
Turn Biotechnologies, Inc.
Mountain View, CA · CIK 0001992229
Offering snapshot reported Sep 6, 2023 · SEC filing
- Reported sold
- $29.1M Offering amount: $43.9M
- Investors reported
- 55 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 22, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 6, 2023 | Initial | $29,132,219 | No comparison | 55 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-491427
Source: Form D, filed Sep 6, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David Gobel | Director |
| Anja Krammer | Director, Executive |
| Ric Peterson | Executive |
| Marco Quarta | Director |
| Sergio Andres Ruiz Chinchilla | Executive |
| Vittorio Sebastiano | Director |
Issuer details
Industry: Other (See others in industry)
Address:
319 N. Bernardo
Mountain View, CA, 94043
Mountain View, CA, 94043